Despite great progress has been made in treatment strategies, colorectal cancer (CRC)
remains the predominant life-threatening malignancy with the feature of high morbidity and …

The purpose of this systematic review was to compare the diagnostic ability of blood markers
for colorectal cancer (CRC). A systematic review of the literature for diagnostic blood …

Colorectal cancer (CRC) is considered the second cause of cancer death worldwide. The
early diagnosis plays a key role in patient prognosis and subsequently overall survival …

Sporadic apoptosis of tumour cells is a commonly observed feature of colorectal cancer
(CRC) and strongly correlates with adverse patient prognosis. The uptake of apoptotic cell …

Background Cachexia is a multifactorial syndrome highly associated with specific tumour
types, but the causes of variation in cachexia prevalence and severity are unknown. While …

Among soluble actors that have emerged as druggable factors, the chemokine interleukin-8
(IL-8) has emerged as a possible determinant of response to immunotherapy and targeted …

Colorectal carcinoma (CRC) is the third most common cancer in terms of diagnosis and the
second in terms of mortality. Recent studies have shown that various proteins, such as …

Cancer is the primary cause of death in economically developed countries and the second
leading cause in developing countries. Colorectal cancer (CRC) is the third most common …

Background Immunomodulatory cytokines and systemic inflammatory markers are important
during cancer development and progression. This study investigated the association and …

The inflammatory process plays a significant role in the development of colon cancer (CRC).
Intestinal cytokine networks are critical mediators of tissue homeostasis and inflammation …